The Potency of Antidiabetic of Psidium guajava Fruit Extract Against Streptozotocin-induced Type 2 Diabetic Rats
Downloads
Background: The chronic disease known as diabetes mellitus is brought on by either the pancreas's inability to make enough insulin or the body's inability to use it. Purpose: This plant finds applications for treating diarrhea, dysentery, gastroenteritis, hypertension, diabetes, caries and pain relief. Purpose: The current study aimed to determine how Psidium guajava fruit extract affected the blood glucose, body weights, and insulin levels of streptozotocin (STZ)-induced diabetic rats over 21 days. Methods: The extract's effectiveness was compared to that of glibenclamide, a common hypoglycemic medication. 30 male Wistar albino rats were divided into 5 groups with 6 animals in each group. V: Normal control (Group-I), diabetic control (Group-II), diabetic rats treated with glibenclamide 0.6mg/kg bw (Group-III), diabetic rats treated with Psidium guajava fruit extract 200 mg/kg bw (Group-IV) and Psidium guajava fruit extract 400 mg/kg bw (Group-V). All group of rats were subjected to evaluation of body weight, blood glucose and serum insulin levels on day 0, 7, 14 and 21 of the experiment. Results: There was significant (P<0.05) decrease in body weight and serum insulin and significant (P<0.05) increase in blood glucose level in Group-II compared to Group-I rats. In the Present study, daily oral administration of Psidium guajava fruit extract at dose rate of 200 and 400 mg/kg bw and glibenclamide at 0.6mg/kg bw in diabetic rats for 21 days showed a progressive improvement in body weight, blood glucose and serum insulin concentration. Conclusion: It can therefore be concluded the results of this study indicate that Psidium guajava fruit extract possesses anti-diabetic properties in Wistar albino rats.
Abdel, W.S.M., Hifawy, M.S, El Goharyand, M., Isak, H.M. 2004. Study of Carbohydrates, Lipids, Protein, Flavonoids, Vitamine Cand Biological Activity of Psidiumguayava L. Growing in Egypt. Egypt Journal Biomedicine Science. 16: 35-52.
Amin, I.M (2011) Hypoglycemic effects in response to Abelmoshus esculentus Treatment: a research framework is used STZ-induced diabetic rats. Int J Biosci Biochem Bioinforma 1:63-67
Babu, P.S., Prince, P.S.M. 2004. Antihyperglycaemic and antioxidant effect of hyponid, an ayurvedic herb mineral formulation in rats. Journal of streptozotocin"induced Pharmacy and diabetic Pharmacology. 56(11):1435-1442.
Begum, S., Hassan, S.I., Siddiqui, B.S., Shaheen, F., Ghayur, M.N., Gilani, A.H. 2002. Triterpenoids from the leaves of Psidium guajava. Phytochemistry. 61(4):399-403
Boyle, J.P., Honeycutt,A.A., Narayan,K.M.V. 2001. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S,” Diabetes Care, 24 (11):1936-1940.
Chika, A., Bello, S.O. 2010. Antihyperglycaemic activity of aqueous leaf extract of Combretum micranthum (Combretaceae) in normal and alloxan-induced diabetic rats,” Journal of Ethnopharmacology. 129(1):34–37,2010.
Dineshkumar, B., Mitra, A., Manjunatha, M. 2010. Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (xanthone glucoside) in streptozotocin-induced type 1 and type 2 diabetic model rats. Int J Ad. Pharm Sci 1:75-85
Eurich, D.T., McAlister, F.A., Blackburnetal, D.F.2007. Benefitsand harms of antidiabetic agents in patients with diabetes and heart failure: systematic review,” British Medical Journal. 335(7618)497-501
Graham, M.L, Janecek, J.L., Kittredge, J.A., Hering, B.J., Schuurman H. 2011. The streptozotocin-induced diabetic nude mouse model: diferences between animals from diferent sources. Comp Med 61(4):356–360
Jimenez-Escrig, A., Rincon, M., Pulido, R., Saura-Calixto, F. 2001. Guava Fruit ( Psidium guajava L.) as a New Source ofAntioxidant Dietary Fiber. Journal of Agricultural andFood Chemistry. 49(11): 5489-93
Junod, A., Lambert, A.E., Orci, L., Pictet, R., Gonet, A.E., Renold, A.E.1967. Studies of the diabetogenic action of streptozotocin. Exp Biol Med 126:201–205
Lozoya, X., Meckes, M., Abou-Zaid, M., Tortoriello, J., Nozzolillo, C., Arnason, J.T. 1994. Quercetin glycosides in Psidium guajava L. leaves and determination of a spasmolytic principle. Arch med res. Archives of Medical Research. 25(1): 11-5.
Malviya, N., Jain, S., Malviya, S. 2010. Antidiabetic potential of medicinal plants,” Acta Poloniae Pharmaceutica, 67(2):113-118
Michael, H.N., Salib, J.Y., Ishak, M.S. 2002. Acylated flavonol gly-coside from Psidium guajava L. seeds. Pharmazie. 57(12): 859-60
Pushparaj, P.N., Tan, C.H. 2007. Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 111(2):430-434
Rheney, C.C., Kirk, J.K. 2000. Performance of three blood glucose meters. Annals of Pharmacotherapy. 34(3):317321.
Sellamuthu, P.S., Muniappan, B.P., Perumal, S.M., Kandasamy, M. 2009. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 55:206–214
Suba, V., Murugesan, T., Bhaskara Rao, R.2004. Antidiabetic potential of Barleria lupulina extract in rats, Fitoterapia,n75(1):1–4
Vieira, B.T., , das Dores RG., Soncin, R.C., Gontijo, E.F.C., Márcia da Silva, T.L., de Paula, S.A. 2014. Antioxidant, antibacterial and antitumor activity of ethanolic extract of the Psidium guajava leaves. American Journal of Plant Sciences. 5: 3492–3500.
Vikrant, A., Narender, T., Kashyap, C.P. 2012. Preliminary Phytochemical Analysis of the Extracts of Psidium Leaves. Journal of Pharmacognosy and Phytochemistry. 2012; 1(1):1-5.
Copyright (c) 2024 Safira Salsabila Citagami, Saninah Candrawati Ruliff
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Journal of Basic Medical Veterinary (JBMV) by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
Perhimpunan Dokter Hewan Indonesia
